Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-NP+M1 + IIV in Older Adults (INVICTUS)
NCT03300362Phase 2Terminated
- Sponsor
- Barinthus Biotherapeutics
- Start
- Oct 2017
- Primary completion
- Oct 2018
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of VTP-100 in influenza, sponsored by Barinthus Biotherapeutics. Started Oct 2017; status: terminated.
02
Drugs
VTP-100
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03300362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03300362.